產品詳情
簡單介紹：
Anti-C12ORF54抗體產品質量穩定，實驗效果明顯，貨期快，價格優惠，歡迎垂詢訂購！我公司長期供應**組化抗體、WB抗體、**組化試劑盒和抗體試驗所需全部相關試劑、熒光標記抗體、單克隆抗體、多克隆抗體、各種標記的二抗IgG/IgM/IgD/IgA等科研實驗抗體。Anti-C12ORF54抗體用于**組化實驗,WB實驗,相應的標記抗體有HRP標記抗體,FITC標記,BIO等。
詳情介紹：
Rabbit Anti-C12ORF54
Cat. Number:
Anti-C12ORF54抗體KL-9952R
Quantity size:
0.2ml
Concentration:
1mg/ml Buffer = 0.01M TBS(pH7.4) with 1% BSA, 0.03% Proclin300 and 50% Glycerol.
Background:
Encoding over 1,100 genes within 132 million bases, chromosome 12 makes up about 4.5% of the human genome. A number of skeletal deformities are linked to chromosome 12 including hypochondrogenesis, achondrogenesis and Kniest dysplasia. Noonan syndrome, which includes heart and facial developmental defects among the primary symptoms, is caused by a mutant form of PTPN11 gene product, Anti-C12ORF54抗體SH-PTP2. Chromosome 12 is also home to a homeobox gene cluster which encodes crucial transcription factors for morphogenesis, and the natural killer complex gene cluster encoding C-type lectin proteins which mediate the NK cell response to MHC I interaction. Trisomy 12p leads to facial development defects, seizure disorders and a host of other symptoms varying in severity depending on the extent of mosaicism and is most severe in cases of complete trisomy. The C12orf54 gene product has been provisionally designated C12orf54 pending further characterization.
Also known as:
MGC35033; C12orf54; Anti-C12ORF54抗體Chromosome 12 open reading frame 54; CL054_HUMAN; HSD 29; HSD 30; HSD29; Uncharacterized protein C12orf54.
Specificity:
●
Rabbit Polyclonal IgG, affinity purified by Protein A.
●
Reacts with: Human, Mouse, Rat, .
●
Immunogen: KLH conjugated synthetic peptide derived from human C12ORF54.
●
Predicted Molecular Weight: 14kDa.
Storage:
Shipped at 4℃, StoreAnti-C12ORF54抗體 at -20℃ (Avoid repeated freeze/thaw cycles).
Application:
WB=1:100-500 ELISA=1:500-1000 IHC-P=1:100-500 IHC-F=1:100-500 IF=1:50-200
Not yet tested in other applications.
Optimal working Anti-C12ORF54抗體dilutions must be determined by the end user.
Not yet tested in other applications.
Optimal working Anti-C12ORF54抗體dilutions must be determined by the end user.
kl128Mu02 組織金屬蛋白酶抑制因子2(TIMP2)多克隆抗體 Polyclonal Antibody to Tissue Inhibitors Of Metalloproteinase 2 (TIMP2)
kl129Mu02 組織金屬蛋白酶抑制因子3(TIMP3)多克隆抗體 Polyclonal Antibody to Tissue Inhibitors Of Metalloproteinase 3 (TIMP3)
kl130Mu02 組織金屬蛋白酶抑制因子4(TIMP4)多克隆抗體 Polyclonal Antibody to Tissue Inhibitors Of Metalloproteinase 4 (TIMP4)
kl131Mu02 轉化生長因子β誘導蛋白(TGFβI)多克隆抗體 Polyclonal Antibody to Transforming Growth Factor Beta Induced Protein (TGFbI)
kl133Mu02 腫瘤壞死因子α(TNFα)多克隆抗體 Polyclonal Antibody to Tumor Necrosis Factor Alpha (TNFa)
kl134Mu02 腫瘤壞死因子β(TNFβ)多克隆抗體 Polyclonal Antibody to Tumor Necrosis Factor Beta (TNFb)
kl135Mu02 血小板生成素(TPO)多克隆抗體 Polyclonal Antibody to Thrombopoietin (TPO)
kl136Mu01 腫瘤壞死因子受體超家族成員10A(TNFRSF10A)多克隆抗體 Polyclonal Antibody to Tumor Necrosis Factor Receptor Superfamily, Member 10A (TNFRSF10A)
kl136Mu02 腫瘤壞死因子受體超家族成員10A(TNFRSF10A)多克隆抗體 Polyclonal Antibody to Tumor Necrosis Factor Receptor Superfamily, Member 10A (TNFRSF10A)
kl139Mu02 腫瘤壞死因子相關凋亡誘導配體(TRAIL)多克隆抗體 Polyclonal Antibody to Tumor Necrosis Factor Related Apoptosis Inducing Ligand (TRAIL)
kl140Mu02 尿激酶型纖溶酶原激活因子(uPA)多克隆抗體 Polyclonal Antibody to Plasminogen Activator, Urokinase (uPA)
kl141Mu02 尿激酶型纖溶酶原激活因子受體(ukl)多克隆抗體 Polyclonal Antibody to Plasminogen Activator, Urokinase Receptor (ukl)
kl142Mu02 細胞間粘附分子5(ICAM5)多克隆抗體 Polyclonal Antibody to Intercellular Adhesion Molecule 5 (ICAM5)
kl144Mu02 血管內皮生長因子B(VEGFB)多克隆抗體 Polyclonal Antibody to Vascular Endothelial Growth Factor B (VEGFB)
kl145Mu02 血管內皮生長因子C(VEGFC)多克隆抗體 Polyclonal Antibody to Vascular Endothelial Growth Factor C (VEGFC)
kl146Mu02 血管內皮生長因子D(VEGFD)多克隆抗體 Polyclonal Antibody to Vascular Endothelial Growth Factor D (VEGFD)
kl147Mu02 脂聯素受體1(ADIPOR1)多克隆抗體 Polyclonal Antibody to Adiponectin Receptor 1 (ADIPOR1)
kl149Mu02 Ⅳ型膠原α1(COL4α1)多克隆抗體 Polyclonal Antibody to Collagen Type IV Alpha 1 (COL4a1)
kl151Mu02 激肽釋放酶3(KLK3)多克隆抗體 Polyclonal Antibody to Kallikrein 3 (KLK3)
kl153Mu02 甲胎蛋白(αFP)多克隆抗體 Polyclonal Antibody to Alpha-Fetoprotein (aFP)
